BIOPATTERN

BIOPATTERN is a groundbreaking project that integrates key elements of European research to underpin eHealth. The goal is to develop a pan-European, intelligent analysis of a citizen's bioprofile; to make the analysis of this bioprofile remotely accessible to patients and clinicians; and to exploit bioprofile to combat major diseases such as cancer and brain diseases.

Today, the ability to produce vast amounts of bio-data has vastly outstripped our ability to sensibly make use of the data for decision making.

A key objective of BIOPATTERN is to address the problem of fragmentation in this key area by bringing together key researchers to create a critical mass of specialists to promote the development of computational intelligence methods underpinning e-Healthcare. The idea is to move away from local solutions to local problems and towards European wide solutions to European problems.

The main objectives are:

  • Integration - to tackle and reduce fragmentation of existing research capacities in this area
  • Virtual Research Institute - to create a new research community
  • New opportunities - to identify how bioprofile could be exploited for healthcare, such as disease prevention, diagnosis and treatment
  • Roadmap - to identify gaps in knowledge, key challenges and to initiate joint activities to address them.
  • Standards - To identify technical and ethical issues on which guidelines and standards should be based with regard to the acquisition, transmission and analysis of a bioprofile
  • Societal challenges - To contribute to finding solutions to some of the demanding societal challenges in healthcare.

For further information, please visit:
http://www.biopattern.org

Project co-ordinator:
University of Plymouth

Partners:

  • University of Plymouth - Plymouth NHS Trust Hospitals - Aston University - University of Liverpool - University of Nottingham - Liverpool John Moores University - Nottingham Trent University - Sheffield Hallam University - BioElf Ltd - Gap Infomedia Ltd (UK)
  • Universita Degli Studi Di Firenze - Universita Degli Studi Di Pisa - Instituto Nazionale Per Lo Studio Cura Dei Tumori, Milano - Universita Degli Studi Di Milano - Synapsis S. R. L (IT)
  • University of Athens Medical School - Telecommunication Systems Institute - Technological Educational Institute of Crete - University of Crete, Medical Division - Aristotelio Panepistimio Thessalonikis - Hellenic Telecommunications & Telematics Applications Company SA (Forthnet) - Daedalus Informatics Ltd (GR)
  • Neoventor Medicinsk Innovation AB - University College Boras (SE)
  • Katholieke Universiteit Leuven Research & Development (BE)
  • Stichting Katholieke Universiteit (NL)
  • Instituto De Desenvolvimento De Novas Tecnologias - (UNINOVA) (PT)
  • Ecological University of Bucharest (FI)
  • University of Malta (MT)

Timetable: from 01/04 - 12/07

Total cost: € 12.800.000

EC funding: € 6.400.000

Instrument: NoE

Project Identifier: IST-2002-508803

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...